MedPath

Prospective Trial of Subcutaneous Versus Subpectoral 2-Staged Implant-Based Breast Reconstruction

Not Applicable
Completed
Conditions
Breast Reconstruction Following Mastectomy
Registration Number
NCT02775409
Lead Sponsor
Mayo Clinic
Brief Summary

This study is for women scheduled to have immediate breast reconstruction following mastectomy using a tissue expander. The primary purpose of this study is to learn whether there are differences in the outcome between placing the tissue expander above the muscle or below the muscle. The study will evaluate pain, wellbeing, and overall satisfaction with reconstruction. A secondary purpose is to learn whether there are differences in complications and costs between the two locations.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
200
Inclusion Criteria
  1. Women at least 18 years of age, who will undergo immediate unilateral or bilateral implant-based breast reconstruction following therapeutic skin-sparing or nipple-sparing mastectomy.
  2. Women at least 18 years of age, who will undergo immediate bilateral implant-based breast reconstruction following risk-reduction (prophylactic) skin-sparing or nipple-sparing mastectomy.
Exclusion Criteria
  1. Subjects who are unable to read or speak English.
  2. Patients desiring autologous reconstruction.
  3. BMI >40.
  4. History of radiation therapy to the breast(s), e.g. history of breast conservation therapy.
  5. Current nicotine and/or tobacco use.
  6. Documented diagnosis of chronic pain.
  7. Women who are pregnant or breast-feeding *
  8. Women who decline the use of acellular dermal matrix (ADM).
  9. Surgeon decision not to proceed with tissue expander reconstruction.
  10. Women undergoing single stage (straight to implant) reconstruction.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Change in patient satisfactionBaseline, Year 3

Difference in patient satisfaction between the two groups using the physical well being scale.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Mayo Clinic

πŸ‡ΊπŸ‡Έ

Rochester, Minnesota, United States

Mayo Clinic
πŸ‡ΊπŸ‡ΈRochester, Minnesota, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.